Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
The many facets of metzincins and their endogenous inhibitors : Perspectives on ovarian cancer progression
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells : Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
Are you sure you would like to clear your session, including search history and login status?